NODULAR UTERINE LEIOMYOMA OF GIANT SIZE ON THE BACKGROUND OF COMBINED EXTRAGENITAL PATHOLOGY (CASE STUDY)
Journal: Zenodo (CERN European Organization for Nuclear Research)
Year: 2022

According to the latest WHO data, over 26 million women, mostly of late reproductive and perimenopausal periods (35-55 y.o.) are diagnosed with uterine leiomyoma (UL) [1]. According to recent publications, the key risk factors for UL may be diabetes mellitus (DM), obesity, hypertension, or a combination of these as part of metabolic syndrome (MS) [2]. Risk factors for MS are hypertension, dyslipidemia, fasting hyperglycemia, and central obesity [3,4]. The aim of the research is to present a clin